Pharma Market Access Insights - from Petauri Evidence
Podcast autorstwa Petauri Evidence
64 Odcinki
-
Navigating US payer evidence needs to optimise market access
Opublikowany: 27.11.2024 -
Best practice RWE approaches to support economic modelling for HTA
Opublikowany: 20.11.2024 -
NHS winter planning 2024–25 – Engaging with NHS decision-makers through Autumn to Christmas
Opublikowany: 18.11.2024 -
De-mystifying the NHS – What you need to know about the NHS as a market for your health technology
Opublikowany: 11.10.2024 -
NHS primary care panel – the GP Contract and Operational Planning Guidance
Opublikowany: 10.09.2024 -
Engage NHS healthcare decision-makers with RWD
Opublikowany: 12.08.2024 -
Market access and reimbursement in Canada – changes at CADTH
Opublikowany: 20.06.2024 -
Rare Disease market access in the MENA and Nordic regions
Opublikowany: 10.05.2024 -
How does funding flow in NHSE Regions?
Opublikowany: 9.04.2024 -
NHS policy for 2024/25: strategy and engagement in a world of uncertainty (recorded in Jan 2024)
Opublikowany: 9.04.2024 -
De-mystifying health economic model classifications and structures
Opublikowany: 22.03.2024 -
Evidence strategy for Medical Technologies and Diagnostics
Opublikowany: 12.03.2024 -
How to set your Pharma or Medtech product up for success in the US market
Opublikowany: 26.02.2024 -
What's happening with specialised commissioning in the NHS?
Opublikowany: 12.02.2024 -
Integrated care in NHS Wales – what can England learn from its neighbour?
Opublikowany: 17.01.2024 -
Market access in Italy: Reforms at AIFA
Opublikowany: 18.12.2023 -
Unmet need in NHS primary care – How can industry best support PCN leaders?
Opublikowany: 28.11.2023 -
Population health management: a community effort across health and life sciences
Opublikowany: 1.11.2023 -
Artificial intelligence (AI) in clinical trials: Implications for evidence synthesis and market access
Opublikowany: 26.10.2023 -
6 areas of UK health policy for Medtech to pay attention to
Opublikowany: 16.10.2023
We explore news and insights from global healthcare markets, advising how pharma and medtech need to respond and adapt their market access strategy in light of the latest insights from our experts. The podcast features insights from our associates across global healthcare, along with thought leadership from the market access and HEOR experts at Petauri Evidence.
